APPLIED MOLECULAR TRANSPORT (AMTI)

US03824M1099 - Common Stock

0.263  -0.04 (-14.3%)

After market: 0.2629 0 (-0.04%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AMTI. AMTI was compared to 588 industry peers in the Biotechnology industry. While AMTI seems to be doing ok healthwise, there are quite some concerns on its profitability. AMTI does not seem to be growing, but still is valued expensively.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

AMTI had negative earnings in the past year.
In the past year AMTI has reported a negative cash flow from operations.
In the past 5 years AMTI always reported negative net income.
In the past 5 years AMTI always reported negative operating cash flow.

1.2 Ratios

AMTI has a Return On Assets of -373.95%. This is amonst the worse of the industry: AMTI underperforms 97.30% of its industry peers.
AMTI has a Return On Equity of -461.67%. This is amonst the worse of the industry: AMTI underperforms 80.61% of its industry peers.
Industry RankSector Rank
ROA -373.95%
ROE -461.67%
ROIC N/A
ROA(3y)-70.66%
ROA(5y)-82.71%
ROE(3y)-106.54%
ROE(5y)-110.95%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AMTI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, AMTI has more shares outstanding
AMTI has a worse debt/assets ratio than last year.

2.2 Solvency

AMTI has an Altman-Z score of -36.49. This is a bad value and indicates that AMTI is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -36.49, AMTI is doing worse than 94.94% of the companies in the same industry.
There is no outstanding debt for AMTI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -36.49
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

AMTI has a Current Ratio of 4.95. This indicates that AMTI is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 4.95, AMTI perfoms like the industry average, outperforming 50.59% of the companies in the same industry.
AMTI has a Quick Ratio of 4.95. This indicates that AMTI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.95, AMTI is in line with its industry, outperforming 51.94% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.95
Quick Ratio 4.95

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 45.09% over the past year.
EPS 1Y (TTM)45.09%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q73.85%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2QN/A

3.2 Future

Based on estimates for the next years, AMTI will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.45% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y70.28%
EPS Next 2Y32.75%
EPS Next 3Y14.38%
EPS Next 5Y12.45%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AMTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AMTI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

AMTI's earnings are expected to grow with 14.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.75%
EPS Next 3Y14.38%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AMTI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

APPLIED MOLECULAR TRANSPORT

NASDAQ:AMTI (12/26/2023, 7:00:01 PM)

After market: 0.2629 0 (-0.04%)

0.263

-0.04 (-14.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap11.01M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -373.95%
ROE -461.67%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.95
Quick Ratio 4.95
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)45.09%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y70.28%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y